Project: A novel platform for more efficient and TRANSlatable pre-Clinical rEsearch oN parkinson’s Disease
| Acronym | TRANSCEND (Reference Number: 114817) |
| Duration | 01/04/2021 - 01/04/2024 |
| Project Topic | This project will accelerate drug development for Parkinson’s Disease (PD) by delivering the TRANSCEND platform, a novel drug screening solution including a microglia-integrated Brain-on-Chip model fully mimicking the 3D human brain complexity together with a novel, unique humanized mouse model. The TRANSCEND platform will be the first to offer a complete, integrated solution for translatable preclinical research on human tissue, allowing highly improved drug screening for new treatments for PD. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 14 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | InnoSer België NV | Coordinator | Belgium |
| 2 | Neurix SA | Partner | Switzerland |
| 3 | Université de Genève | Partner | Switzerland |